Dr. Philip Santangelo Professor Georgia Institute of Technology

Dr. Santangelo is currently a Professor in the Wallace H. Coulter Department of Biomedical Engineering, at Emory University and Georgia Tech. He received his PhD from the University of California at Davis in 1998 and was a postdoctoral fellow at Sandia National Labs in Livermore, CA, from 1998-2000, and a postdoc/research-scientist at Georgia Tech from 2002 until 2007. His background is a diverse mixture of engineering, physics, chemistry and biology, with an emphasis on working at the interface of multiple disciplines. His research interests are focused on the development of novel imaging probes, the pathogenesis of viruses, the spatial dynamics of immune responses to viral infections and transplants, and the development of mRNA-based therapies and vaccines. In the area of novel imaging probes, he developed the first PET contrast agent for SIV and SHIV infections, as well as applied PET imaging to the interrogation of mRNA-based vaccines. In the field of mRNA-based therapeutics, he has spearheaded the development of a molecular toolbox for characterizing mRNA delivery and the development of new applications of mRNA, including the delivery of mRNA-encoded antibodies and CRISPR proteins to mucosal interfaces, with emphasis on the lung and female reproductive tract.

Presenting at:

All times are presented in the host university’s local time zone.

Wednesday, October 26, 2022

RNA-Based Drug and Diagnostic Development
(9:10am - 9:55am)

You are now leaving the website that is under the control and management of DARPA. The appearance of hyperlinks does not constitute endorsement by DARPA of non-U.S. Government sites or the information, products, or services contained therein. Although DARPA may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.

After reading this message, click  to continue immediately.

Go Back